Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN
BlackRock, Inc. reported a 14.70% stake in Supernus Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 22, 2025
BlackRock, Inc. reported a 14.70% stake in Supernus Pharmaceuticals, Inc., 8,197,023 shares, as a passive investor on Mar 31, 2025. Filed Apr 22, 2025 (Schedule 13G/A).
- Stake
- 14.70%
- Shares
- 8,197,023
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 14.70% | 8,197,023 |